ABSTRACT
The first aim of our study was to synthesize two new ligands acting as S-alkenyl derivatives of thiosalicylic acid (alkenyl = propenyl-(L1), isobutenyl-(L2)), and two corresponding copper(II)-complexes with these ligands. The composition and structure of S-alkenyl derivatives of thiosalicylic acid was assumed on the basis of microanalysis, IR, and NMR spectroscopy. The composition and structure of synthesized complexes was confirmed based on the microanalysis, IR spectroscopy, and magnetic measurements. Another aim of our study was to investigate the cytotoxic potential of copper(II)-complexes with S-alkenyl derivatives of thiosalicylic acid on the human colon cancer cell line HCT-116.
MATERIALS AND METHODS

Materials and measurements
The reagents were obtained commercially and used without further purification. Elemental analyses were conducted on a Vario III CHNOS Elemental Analyser, Elemental Analysensysteme GmbH. For infrared spectra, a Perkin-Elmer FTIR 31725-X spectrophotometer, and KBr pellet technique were employed.
Syntheses
General procedure for the synthesis of S-alkenyl derivatives of thiosalicylic acid
The S-alkenyl derivatives of the thiosalicylic acid ligand (alkenyl = propenyl-(L1), isobutenyl-(L2)) were prepared (26) by alkylation of thiosalicylic acid using the corresponding alkenyl halides in alkaline water-ethanol solution.
S-propenyl derivative of thiosalicylic acid (S-propenylthiosal), (L1): M.p. 180-181ºC, white powder, IR (KBr, cm 
INTRODUCTION
After successful application of "cisplatin" (cisdiamminedichloroplatinum(II)) to chemotherapy in cancer patients, the exploration of other metal-complexes as new anticancer agents has continued, to enhance their specificity towards cancer cells, reduce toxic side effects, and prevent the development of resistance in human cancer cells (1) (2) (3) (4) (5) .
Copper is an essential element for all organisms who live in environments rich in oxygen. This redox active metal converts oxidation state easily from a Cu(I) to Cu(II), and vice versa, as in chemical reactions and in physiological conditions (6) . Copper is essential for the function of several enzymes and proteins, such as cytochrome oxidase, Zn, Cu-superoxide dismutase, lysyl oxidase, tyrosinase, and dopamine-b-monooxygenase (1, 6, 7) .
The importance of copper is also reflected in the fact that its deficiency leads to congenital genetic diseases, such as Wilson's disease (VD) and Menkes disease (MD) (8) . Copper chelation therapy has attracted considerable attention for use in research and treatment of various neurodegenerative disorders (9) .
The presence of proteins found in copper has been associated to metabolic changes in cancer cells. The exact role of copper in the treatment of cancer has not been sufficiently clarified (6, 10) . It is assumed that copper is involved in the generation of ROS (reactive oxygen species) and the process of angiogenesis by stimulating the proliferation and migration of human endothelial cells (10) (11) (12) .
Thiosalicylic acid and its derivatives have a wide range of applications. It has been used for the determination of metals (13, 14) ; as modifiers of graphite paste electrodes (15) ; as photoinitiators of free radical polymerization (16); in cosmetics (17) ; in the treatment of dermatological (18), inflammatory, allergic, and respiratory diseases (19) ; and as Ras-tumour growth inhibitors (20) .
Copper(II)-complexes may exert cytotoxic activity on colon carcinoma cell lines. O'Halloran found that a copper complex (Cu[N-salicylidene-(glutamate)(H 2 O) 2 ]·H 2 O) at concentrations of 50 and 100 μmol/L was shown to have distinct cytotoxic activity in human HT-29 colon cancer cells after 72 hours. Apoptosis was activated by the generation of large quantities of free radicals (21) .
Various studies have confirmed the synthesis and structural characterization of different complexes of copper(II) with thiosalicylic acid as a ligand (22, 23) . Complexes of copper(II) with the S-alkyl derivatives of thiosalicylic acid showed moderate antimicrobial activity and low antifungal activity (24) . With consideration for these effects, new research examining the cytotoxic potential of copper(II) with S-alkyl derivatives of thiosalicylic acid has found that these derivatives exhibit a lower cytotoxicity compared to cisplatin in the human HCT-116 cell line and in murine cell lines CT26 and CT26.CL25 (25) . tained in DMEM (Sigma Aldrich, Munich, Germany) supplemented with 10% fetal bovine serum (FBS, Sigma Aldrich, Munich, Germany), penicillin (100 IU/mL), and streptomycin (100 μg/mL) in a humidified atmosphere of 95% air and 5% CO 2 at 37°C. Subconfluent monolayers in the logarithmic growth phase were harvested by a brief treatment with 0.25% trypsin and 0.02% EDTA in phosphate-buffered saline (PBS, PAA Laboratories GmbH) and washed three times in serum-free PBS. The number of viable cells was determined by trypan blue exclusion.
Cytotoxicity assays
The effects of the tested compounds on cell viability were determined using the MTT colorimetric technique (27) . HCT-116 cells were diluted with growth medium to 5·10 4 cells/mL, and aliquots (5·10 3 cells/100 mL) were placed in individual wells in 96-well plates. The next day the medium was exchanged with 100 μL of different compounds, which had been serially diluted 2-fold in the medium to concentrations ranging from 1000 μM to 7.8 μM in growth medium. Each compound was tested in triplicate. Cells were incubated at 37°C in 5% CO 2 for 72 h. After incubation the supernatant was removed, and 15% MTT solution (5 mg/mL in PBS, 10 μL) in DMEM without FBS was added to each well. After an additional 4 h of incubation at 37°C in 5% CO 2 , the medium with MTT was removed and DMSO (150 μL) with glycine buffer (20 μL) was added to dissolve the crystals. The plates were shaken for 10 min. The optical density of each well was determined at 595 nm using microplate Zenyth 3100 Multimode detector. The percentage of cytotoxicity was calculated using the formula: % cytotoxicity = 100-((E-B)/(S-B)·100), where B is the background of medium alone, S is total viability/ spontaneous death of untreated target cells, and E is experimental well. Each of the tested complexes was evaluated for cytotoxicity in three separate experiments.
RESULTS AND DISCUSSION
Synthesis and chemical characterization S-alkenyl (R = propenyl-(L1), isobutenyl-(L2)
) derivatives of thiosalicylic acid were prepared (26) by alkylation of thiosalicylic acid using the corresponding alkenyl halogenides in an alkaline water-ethanol solution (Scheme 1). The corresponding complexes were obtained by a direct mmol) was subsequently added. The reaction mixture was heated for 3 h, and during this period 10.0 ml of LiOH water solution (0.0199 g, 0.8278 mmol) was added in small portions. The solution was filtered and evaporated to a small volume. The blue precipitate of copper(II)-complex was separated by filtration, washed with cold water, and air-dried. Yield: 0.1604 g (81.5%). Anal. Calc. for [Cu 2 (S-propenyl-thiosal) 4 
Preparation of copper(II)-complex with S-isobutenyl derivative of thiosalicylic acid [Cu 2 (S-isobutenylthiosal) 4 (H 2 O) 2 ] (C2)
Copper ( 
Preparation of drug solutions
Complexes were dissolved in 10% dimethylsulfoxide (DMSO) in distilled water at a concentration of 10 mM and filtered through a 0.22 mm Millipore filter. These stock solutions were diluted in culture medium immediately before use. MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5--diphenyl tetrazolium bromide was dissolved (5 mg/mL) in a phosphate buffer saline having a pH of 7.2, and filtered through the 0.22 mm Millipore filter before use. All reagents were purchased from Sigma Chemicals.
Cell culture
HCT-116 cells were kindly provided by Dr Danijela Vignjević (Institute Curie, Paris, France). Cells were mainScheme 1. Synthesis mеthod of S-alkenyl derivates of thiosalicylic acid, R = propenyl-(L1), isobutenyl-(L2).
results from structurally similar ligands, we can conclude that there was a coordination of S-alkenyl derivatives of thiosalicylic acid with copper(II)-ions in forming binuclear complexes.
Additionally, the strong sharp single symmetric stretching bands of the coordinated carboxyl groups of the S-alkenyl derivatives of thiosalicylic acid lie in the expected region (approximately 1400 cm -1 ).
Magnetic measurements
Binuclear copper(II)-complexes (31, 32) (33) (34) (35) . The main factor determining the magnitude of the antiferromagnetic interaction in the dimeric copper(II) carboxylates is the electronic structure of the bridging OCO moiety, as published previously (31, (32) (33) (34) (35) .
Anticancer activity of copper(II)-complexes
The MTT assay for cell viability shows that the two newly synthesized precursor S-alkenyl derivatives of thiosalicylic acid, as well as their corresponding copper(II)-complexes, exhibit cytotoxic activity in HCT-116 human colon carcinoma cells after 24 hours (Figure 1 ). The cytotoxic effect of the copper(II)-complexes was higher than the cytotoxicity of the corresponding ligands, especially for concentrations from 31.25 to 250 μM. Copper complexes showed slightly lower cytotoxicity compared to cisplatin. However, higher concentrations of C2 (250-1000 μM) had an almost equal cytotoxic effect on HCT-116 cells, relative to cisplatin. reaction of copper(II)-nitrate trihydrate with S-alkenyl derivatives of thiosalicylic acid (molar ratio 1:2) in a water solution with satisfactory yields (more than 80%) (Scheme 2).
Infrared spectra of the isolated complexes were measured to find the coordination mode of the S-alkenyl derivatives of thiosalicylic acid. The asymmetric stretching frequencies of the carboxyl group were used to determine whether it was coordinated (the absorption bands are located in the region 1600-1650 cm ) to the metal ion (28) (29) (30) . The infrared spectra of complexes C1 and C2 indicated that the carboxyl groups of S-alkenyl derivatives of thiosalicylic were definitely coordinated to the central copper(II)-complexes.
The isolated (Cu 2 (S-alkenyl-thiosal) 4 (H 2 O) 2 ] complexes show double sharp and strong asymmetric stretching frequencies of the carboxyl groups of the coordinated Salkenyl derivatives of thiosalicylic acid to Cu(II)-ion at approximately 1548-1615 cm -1 ( Table 1 ). The observed clear double bands for isolated complexes suggest small differences in the coordination of the carboxyl groups of the ligands to the copper(II)-ion. Based on previously published Scheme 2. Synthesis of copper(II)-complex with S-alkenyl derivates of thiosalicylic acid, R = propenyl-(C1), isobutenyl-(C2). 
